| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/SJ.CR.7290282 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/sj.cr.7290282 |
| P698 | PubMed publication ID | 15780178 |
| P5875 | ResearchGate publication ID | 7955261 |
| P2093 | author name string | Chen-Lung Steve Lin | |
| Jacqueline Kwai-Yi Chan | |||
| Nancy Pei-Yee Chung | |||
| Shin Ling Hwang | |||
| P2860 | cites work | Prevention of allogeneic fetal rejection by tryptophan catabolism | Q24336018 |
| Dendritic cells and the control of immunity | Q27860918 | ||
| Inhibition of T cell proliferation by macrophage tryptophan catabolism | Q28142922 | ||
| Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase | Q28204166 | ||
| Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndrome | Q28268913 | ||
| Indoleamine 2,3-dioxygenase: antioxidant enzyme in the human eye | Q28290630 | ||
| An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. | Q34036919 | ||
| Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa | Q34275205 | ||
| IDO and tolerance to tumors | Q35628246 | ||
| Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan | Q36254619 | ||
| Macrophage-tropic HIV induces and exploits dendritic cell chemotaxis | Q36368696 | ||
| Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites | Q36376598 | ||
| Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma. | Q38450454 | ||
| Inhibition of tumor cell growth by interferon-gamma is mediated by two distinct mechanisms dependent upon oxygen tension: induction of tryptophan degradation and depletion of intracellular nicotinamide adenine dinucleotide | Q40511488 | ||
| Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. | Q43514619 | ||
| Blockade of tryptophan catabolism prevents spontaneous tolerogenicity of liver allografts | Q43552527 | ||
| IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase | Q43664739 | ||
| Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis | Q44088414 | ||
| Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection. | Q44124436 | ||
| Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase | Q44135171 | ||
| T cell apoptosis by tryptophan catabolism | Q44137068 | ||
| Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. | Q44807466 | ||
| Regulation of indoleamine 2,3-dioxygenase activity in the small intestine and the epididymis of mice | Q46626083 | ||
| Specific induction of indoleamine 2,3-dioxygenase by bacterial lipopolysaccharide in the mouse lung | Q72101553 | ||
| Antibodies to quinolinic acid and the determination of its cellular distribution within the rat immune system | Q72532813 | ||
| Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation | Q73567305 | ||
| Reciprocal control of T helper cell and dendritic cell differentiation | Q74452751 | ||
| Dendritic cell chemotaxis and transendothelial migration are induced by distinct chemokines and are regulated on maturation | Q77714959 | ||
| P433 | issue | 3 | |
| P921 | main subject | dendritic cell | Q506253 |
| chemotaxis | Q658145 | ||
| P304 | page(s) | 167-175 | |
| P577 | publication date | 2005-03-01 | |
| P1433 | published in | Cell Research | Q1524018 |
| P1476 | title | Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines | |
| P478 | volume | 15 |
| Q27863347 | 1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity |
| Q37225714 | A phase I study of indoximod in patients with advanced malignancies |
| Q38941777 | ANALYSIS OF DENDRITIC CELL STIMULATION UTILIZING A MULTI-FACETED NANOPOLYMER DELIVERY SYSTEM AND THE IMMUNE MODULATOR 1-METHYL TRYPTOPHAN. |
| Q94572170 | Age-related increase of kynurenine enhances miR29b-1-5p to decrease both CXCL12 signaling and the epigenetic enzyme Hdac3 in bone marrow stromal cells |
| Q47163506 | Amino acids as modulators of the European seabass, Dicentrarchus labrax, innate immune response: an in vitro approach. |
| Q37357710 | An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells |
| Q39403381 | Aspects of Tryptophan and Nicotinamide Adenine Dinucleotide in Immunity: A New Twist in an Old Tale |
| Q38979523 | Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO. |
| Q24648682 | Binding immunoglobulin protein-treated peripheral blood monocyte-derived dendritic cells are refractory to maturation and induce regulatory T-cell development |
| Q90811952 | Biomarqueurs prédictifs de réponse aux inhibiteurs de points de contrôle immuns |
| Q35848881 | CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques |
| Q38705909 | Central Nervous System Infection with Borna Disease Virus Causes Kynurenine Pathway Dysregulation and Neurotoxic Quinolinic Acid Production |
| Q39356675 | Chromatographic analysis of tryptophan metabolites. |
| Q64243032 | Control of the Antitumor Immune Response by Cancer Metabolism |
| Q36507598 | Dysregulated expression of IDO may cause unexplained recurrent spontaneous abortion through suppression of trophoblast cell proliferation and migration |
| Q46737044 | Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12. |
| Q90169765 | Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs |
| Q36944802 | IDO-expressing regulatory dendritic cells in cancer and chronic infection |
| Q37281950 | IDO: a double-edged sword for T(H)1/T(H)2 regulation |
| Q36024656 | Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure). |
| Q46407536 | Immunotherapy for Pediatric Brain Tumors |
| Q34655953 | Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. |
| Q38274532 | Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model |
| Q39445647 | Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis |
| Q35216385 | Myeloid differentiation primary response protein 88 blockade upregulates indoleamine 2,3-dioxygenase expression in rheumatoid synovial fibroblasts |
| Q33999649 | Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). |
| Q94546987 | Permissive State of EMT: The Role of Immune Cell Compartment |
| Q37329155 | Plasma amino acids changes in complex regional pain syndrome |
| Q57182358 | Protein deficiency reduces efficacy of oral attenuated human rotavirus vaccine in a human infant fecal microbiota transplanted gnotobiotic pig model |
| Q26746113 | Regulatory T Cells: Molecular Actions on Effector Cells in Immune Regulation |
| Q37610449 | Role of IDO in organ transplantation: promises and difficulties |
| Q35772650 | Soluble CD40 ligand contributes to dendritic cell-mediated T-cell dysfunction in HIV-1 infection |
| Q50803151 | The subsets of dendritic cells and memory T cells correspond to indoleamine 2,3-dioxygenase in stomach tumor microenvironment. |
| Q35785085 | Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection |
Search more.